Marijuana firm Invictus to spin off vape subsidiary in move to tap US, global markets

Canadian cannabis producer Invictus plans to spin off wholly owned subsidiary Poda Technologies as it looks to tap into U.S. and global business opportunities.

The Vancouver-based firm, which trades on the TSX Venture Exchange under the ticker symbol GENE, plans to turn Poda into a stand-alone entity valued at roughly $1.9 million, according to a news release.

Canada’s TMX Group – the nation’s largest exchange operator – has warned that publicly traded cannabis firms with holdings south of the border could be delisted because of the plant’s federally illegal status in the U.S.

That situation has led a growing number of Canadian cannabis firms to sell off or spin off their U.S.-based assets.

Poda is a zero-cleaning vaporizer system that can be used with vaporizable substances that include cannabis, tobacco, e-liquids, concentrates, coffee and more.

Under the proposed arrangement:

  • Each common share of Invictus will be exchanged for one new common share of the company and one Poda common share.
  • Each Invictus stock option will be exchanged for one new stock option of Invictus and one Poda stock option.
  • Each Invictus warrant will be exchanged for one new warrant of the company and one Poda warrant.

Upon completion of the spinoff, Poda will apply to list its common shares on the Canadian Securities Exchange. Management of Invictus and Poda will remain the same once the deal is completed, the company said.

Invictus officials were not immediately available for comment.

One comment on “Marijuana firm Invictus to spin off vape subsidiary in move to tap US, global markets
  1. Pharmacy Online on

    EQ: Invictus announced recently that its subsidiary Acreage Pharms received its sales license from Health Canada. This is a crowning milestone for Invictus. Obviously, it is a very significant development for the company, but can you put into words the impact this has on your strategic roadmap and growth trajectory going forward?

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *